Icon

CILOXAN (nda019992)- (EQ 0.3% BASE)

CIPROFLOXACIN HYDROCHLORIDE SANDOZ
EQ 0.3% BASE
No No
2004-Jun-09 Expired
None None
None No
CILOXAN Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus (Viridans Group), Conjunctivitis: Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae.
6 0 5
Total Other Developers None
Drugs with Suitability No
EQ 0.3% BASE ** ** - 1 -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** *** ***** ********* ******* *** (*** *****) *********** **** **** ***** ***., *******, ******** (**) *****, ****** ****** (***) ***
****** ******* ****** *** ***** ********* ******* *** (*** *****) *********** ** ******** *** *** *, ********, *** ****** (**) *****-****, ****** ****** (***) ***
****** *** *** *** ******* *********** *-*,**** ********** ****, *****, **********, *********** ******, ***** (***) ***
****** ****** ****** ******** ******* *********** *** *****-** & ***, *-**,**,**, ***** ********** ****, *****, ***, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.